Literature DB >> 9747403

Randomised controlled trial of compliance therapy. 18-month follow-up.

R Kemp1, G Kirov, B Everitt, P Hayward, A David.   

Abstract

BACKGROUND: A randomised controlled trial was conducted in an acute treatment setting to examine the effectiveness of compliance therapy, a brief pragmatic intervention targeting treatment adherence in psychotic disorders, based on motivational interviewing and recent cognitive approaches to psychosis.
METHOD: Seventy-four patients with psychotic disorders according to DSM-III-R criteria recruited from consecutive admissions to an acute in-patient unit, received 4-6 sessions of either compliance therapy or non-specific counselling, and were followed-up over 18 months. The principal outcome measures were observer-rated compliance, attitudes to treatment, insight and social functioning.
RESULTS: Significant advantages were found for the compliance therapy group post-treatment on measures of insight, attitudes to treatment and observer-rated compliance which were retained over the follow-up period. Global social functioning improved relatively more over time in the compliance therapy group compared with the control group. Survival in the community prior to readmission was significantly longer in the compliance therapy group.
CONCLUSIONS: The results support the effectiveness of compliance therapy in improving functioning and community tenure after an acute psychotic episode.

Entities:  

Mesh:

Year:  1998        PMID: 9747403     DOI: 10.1192/bjp.172.5.413

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  70 in total

Review 1.  A clinical review of cognitive therapy for schizophrenia.

Authors:  Neil A Rector; Aaron T Beck
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

2.  The interrelation of needs and quality of life in first-episode schizophrenia.

Authors:  Karin Landolt; Wulf Rössler; Tom Burns; Vladeta Ajdacic-Gross; Silvana Galderisi; Jan Libiger; Dieter Naber; Eske M Derks; René S Kahn; W Wolfgang Fleischhacker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-24       Impact factor: 5.270

Review 3.  Elderly patients with schizophrenia and depression: diagnosis and treatment.

Authors:  Kandi Felmet; Sidney Zisook; John W Kasckow
Journal:  Clin Schizophr Relat Psychoses       Date:  2011-01

Review 4.  Cognitive behavioural therapy (brief versus standard duration) for schizophrenia.

Authors:  Farooq Naeem; Saeed Farooq; David Kingdon
Journal:  Cochrane Database Syst Rev       Date:  2015-10-21

Review 5.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

Review 6.  Motivational interviewing: a systematic review and meta-analysis.

Authors:  Sune Rubak; Annelli Sandbaek; Torsten Lauritzen; Bo Christensen
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

7.  A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART.

Authors:  Carol E Golin; Joanne Earp; Hsiao-Chuan Tien; Paul Stewart; Carol Porter; Lynn Howie
Journal:  J Acquir Immune Defic Syndr       Date:  2006-05       Impact factor: 3.731

8.  Measuring strategies used by mental health providers to encourage medication adherence.

Authors:  Beth Angell
Journal:  J Behav Health Serv Res       Date:  2006-01       Impact factor: 1.505

Review 9.  Guidelines for clinical treatment of early course schizophrenia.

Authors:  Matcheri S Keshavan; Mary Roberts; Daniela Wittmann
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

10.  The future of pharmacotherapy for schizophrenia.

Authors:  John M Kane; Anil Malhotra
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.